PMID: 15243315Jul 10, 2004Paper

Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected?

Gastroentérologie Clinique Et Biologique
Pierre MichelBernard Paillot

Abstract

In asymptomatic patients presenting with non-resectable synchronous metastatic disease from colorectal adenocarcinoma, the beneficial effect of resecting the primary tumor remains to be documented. The aim of this study was to compare survival of patients with metastatic colorectal cancer who underwent elective resection of the primary tumor to those who did not. A retrospective analysis of patients with metastatic colo-rectal cancer treated between June, 1996 and December, 1999 was performed. Overall survival was compared between patients who underwent first-line resection of the primary colorectal tumor (group 1) or those who did not undergo elective resection of the primary (group 2). The probability of surgical resection of the primary tumor for gastrointestinal complications in group 2 was evaluated. Thirty-one and 23 patients were included in groups 1 and 2 respectively. Five patients (21.7%, 95% confidence interval CI95% 4.9-38.5%) in group 2 required surgical treatment for intestinal obstruction due to the primary tumor. Two clinical characteristics were significantly different between groups 1 and 2: rectal localization (9.7% versus 34.7%; P=0.03) and presence of fewer than three metastases (29.0% versus 4.3%; P=0.03)....Continue Reading

References

Jul 1, 1981·Diseases of the Colon and Rectum·J Joffe, P H Gordon
Jan 23, 1999·Journal of the American College of Surgeons·W R JarnaginL H Blumgart

❮ Previous
Next ❯

Citations

May 9, 2007·International Journal of Colorectal Disease·Hae Ran YunHo-Kyung Chun
Dec 25, 2009·Surgical Endoscopy·Yosuke FukunagaHarushi Osugi
Mar 15, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Sigmar StelznerHelmut Witzigmann
Jun 15, 2010·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Jung Wook HuhYoung Jin Kim
May 15, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·C D MannUNKNOWN Leicester Colorectal Specialist Interest Group
Dec 24, 2010·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·A E M van der PoolC Verhoef
Sep 9, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S AnwarN A Scott
Jul 27, 2011·Therapeutic Advances in Medical Oncology·George A Poultsides, Phillip B Paty
Mar 17, 2009·World Journal of Surgical Oncology·Martyn D EvansJeffrey D Stamatakis
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George A PoultsidesPhillip B Paty
Jun 2, 2007·Annals of Surgical Oncology·Renato CostiLeopoldo Sarli
Feb 7, 2008·Annals of Surgical Oncology·Wai Lun LawOswens S H Lo
Jun 10, 2009·Annals of Surgical Oncology·Srinevas K ReddyBryan M Clary
Mar 18, 2011·World Journal of Gastroenterology : WJG·Sean M Ronnekleiv-Kelly, Gregory D Kennedy
Sep 12, 2013·World Journal of Gastroenterology : WJG·Xiao-Dan ZhaoRui-Hua Shi
Dec 4, 2013·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Walter Y TsangJason A Zell
Mar 19, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·L de MestierO Bouché
Sep 27, 2012·Techniques in Coloproctology·A A P SlesserP P Tekkis
Feb 24, 2010·World Journal of Surgery·Christina CelliniMatthew G Mutch
Nov 21, 2009·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M KarouiD Cherqui
May 9, 2009·Gastroentérologie Clinique Et Biologique·D TougeronP Michel
Jul 23, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·A BajwaA O'Bichere
Dec 8, 2006·Gastroentérologie Clinique Et Biologique·Olivier BoucheChristophe Tournigand
Jun 6, 2007·Surgical Oncology·Bradley J Champagne, Conor P Delaney
Apr 19, 2015·World Journal of Surgical Oncology·Woubet T Kassahun
Dec 4, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Matthieu FaronMichel Ducreux
Apr 13, 2010·International Journal of Surgery·Muhammad Imran AslamJohn Stuart Jameson
Apr 28, 2007·International Journal of Surgery·Andrew G HillIan P Bissett
Jun 28, 2014·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·R Kube, P Mroczkowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.